HCA logo HCA Healthcare +
HCA Healthcare
+

HCA Healthcare Competitors & Alternatives

HCA Healthcare competitors and alternatives

Jump
Company
Company
Ticker
HCA
Headquarter
Nashville ,TN
US
CEO
Samuel N. Hazen
Industry
Medical - Care Facilities
Stock Price
Stock Price
Market Cap
Market Cap
$95.25 B
Employees
Years
  • 2023
  • 2024
  • 2025
Employees
  • 220.00 K
  • 226.00 K
  • 320.00 K
Y/Y
6.28%
2.73%
41.59%

Income Statement

Revenue
Years
  • 2023
  • 2024
  • 2025
Revenue
  • $64.97 B
  • $70.60 B
  • $75.60 B
Y/Y
7.86%
8.67%
7.08%
Revenue by Products / Services
Years
  • 2025
Revenue by Geography
Years
  • 2025
Research and Development
Years
  • 2023
  • 2024
  • 2025
Research and Development
  • -
  • -
  • -
Y/Y
0%
0%
0%
Operating Income
Years
  • 2023
  • 2024
  • 2025
Operating Income
  • $9.63 B
  • $10.55 B
  • $11.97 B
Y/Y
6.34%
9.56%
13.44%
Tax Rate (%)
Years
  • 2023
  • 2024
  • 2025
Tax Rate (%)
  • 20.96%
  • 21.89%
  • 20.85%
Y/Y
2.99%
4.47%
4.77%
Net Income
Years
  • 2023
  • 2024
  • 2025
Net Income
  • $5.24 B
  • $5.76 B
  • $6.78 B
Y/Y
7.11%
9.88%
17.78%
Revenue Per Employee
Years
  • 2023
  • 2024
  • 2025
Revenue Per Employee
  • $295.31 K
  • $312.40 K
  • $236.25 K
Y/Y
1.49%
5.79%
24.38%
Net Income Per Employee
Years
  • 2023
  • 2024
  • 2025
Net Income Per Employee
  • $23.83 K
  • $25.49 K
  • $21.20 K
Y/Y
12.6%
6.96%
16.82%

Assets & Liabilities | Cash Flow

Total Assets
Years
  • 2023
  • 2024
  • 2025
Total Assets
  • $56.21 B
  • $59.51 B
  • $60.72 B
Y/Y
7.2%
5.87%
2.03%
Total Liabilities
Years
  • 2023
  • 2024
  • 2025
Total Liabilities
  • $55.15 B
  • $58.96 B
  • $63.49 B
Y/Y
5.03%
6.9%
7.69%
Capital Expenditures (Capex)
Years
  • 2023
  • 2024
  • 2025
Capital Expenditures (Capex)
  • -$4.74 B
  • -$4.88 B
  • -$4.94 B
Y/Y
7.94%
2.76%
1.42%

Profitability

Operating Income Margin (%)
Years
  • 2023
  • 2024
  • 2025
Operating Income Margin (%)
  • 14.82%
  • 14.94%
  • 15.83%
Y/Y
1.41%
0.81%
5.95%
Net Income Margin (%)
Years
  • 2023
  • 2024
  • 2025
Net Income Margin (%)
  • 8.07%
  • 8.16%
  • 8.97%
Y/Y
13.88%
1.11%
9.99%
EBITDA
Years
  • 2023
  • 2024
  • 2025
EBITDA
  • $12.72 B
  • $13.90 B
  • $15.60 B
Y/Y
4.28%
9.24%
12.28%
Free Cash Flow (FCF)
Years
  • 2023
  • 2024
  • 2025
Free Cash Flow (FCF)
  • $4.69 B
  • $5.64 B
  • $7.69 B
Y/Y
13.57%
20.31%
36.41%

Ratios

Return on Equity (ROE)
Years
  • 2023
  • 2024
  • 2025
Return on Equity (ROE)
  • -295.49%
  • -230.49%
  • -112.56%
Y/Y
44.89%
22%
51.17%
Return on Assets (ROA)
Years
  • 2023
  • 2024
  • 2025
Return on Assets (ROA)
  • 9.33%
  • 9.68%
  • 11.17%
Y/Y
13.34%
3.79%
15.44%
Debt to Equity
Years
  • 2023
  • 2024
  • 2025
Debt to Equity
  • -2,359.58%
  • -1,810.20%
  • -832.89%
Y/Y
62.41%
23.28%
53.99%

Valuation

Enterprise Value
Years
  • 2023
  • 2024
  • 2025
Enterprise value
  • $114.66 B
  • $120.92 B
  • $156.87 B
Y/Y
5.23%
5.46%
29.72%
Enterprise value to Revenue
Years
  • 2023
  • 2024
  • 2025
Enterprise value to Revenue
  • 1.76
  • 1.71
  • 2.07
Y/Y
2.44%
2.95%
21.15%
Enterprise value to EBITDA
Years
  • 2023
  • 2024
  • 2025
Enterprise value to EBITDA
  • 9.01
  • 8.70
  • 10.05
Y/Y
9.93%
3.45%
15.53%

Related company

Submit feedback to Bullfincher